If you are considering Dihexa use, you must consult with a qualified healthcare professional, preferably one with neuropharmacology expertise
It is not yet clear whether the proposed metabolic constraints are specific to GLP-1RA therapy or represent a broader feature of sustained caloric restriction and weight loss [49, 50]
Tirzepatide produces sustained metabolic changes over months, with durability supported by the STEP clinical trial series showing weight reductions of 1522% at maintenance doses
[DOI] [PubMed] [Google Scholar] 27.Sabullah M., Shukor M.Y., Sulaiman M.R., Shamaan N., Syed M., Khalid A., Ahmad S
Transcripts were considered differentially expressed if they showed an absolute fold change (|FC|) 1.5 and an adjusted p-value 0.05 (BenjaminiHochberg correction)